Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801
- Citation:
- Blood Adv vol 4 (4) 696-705
- Year:
- 2020
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- collection
- Note:
- Pharmas:
- Bristol Meyers Squibb
- Grants:
- U10CA180821, U10CA180882, P30CA033572, U10CA180833, U10CA180836, U10CA180850, U10CA180866, U10CA180867
- Corr. Author:
- Authors:
- Guido Marcucci Susan Geyer Kristina Laumann Weiqiang Zhao Donna Bucci Geoffrey L. Uy William Blum Ann-Kathrin Eisfeld Timothy S. Pardee Eunice S. Wang Wendy Stock Jonathan E. Kolitz Jessica Kohlschmidt Krzysztof Mrózek Clara D. Bloomfield Richard M. Stone Richard A. Larson
- Networks:
- CA043, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NY158, LAPS-OH007, NC002, NORTHWELL
- Study
- CALGB-10801
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-20202
- Phases:
- 2, N/A
- Keywords:
- 20, 25, Clinical Trials and Observations